<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
69693-426-25
</NDCCode>
<PackageDescription>
1 BOTTLE, WITH APPLICATOR in 1 CARTON (69693-426-25) / 118 mL in 1 BOTTLE, WITH APPLICATOR
</PackageDescription>
<NDC11Code>
69693-0426-25
</NDC11Code>
<ProductNDC>
69693-426
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Absorbine Jr. Pro Rollon
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Absorbine Jr. Pro Rollon
</NonProprietaryName>
<DosageFormName>
LIQUID
</DosageFormName>
<RouteName>
TOPICAL
</RouteName>
<StartMarketingDate>
20251227
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH DRUG
</MarketingCategoryName>
<ApplicationNumber>
M017
</ApplicationNumber>
<LabelerName>
Clarion Brands, LLC
</LabelerName>
<SubstanceName>
LIDOCAINE; PHENOL
</SubstanceName>
<StrengthNumber>
4; 1.5
</StrengthNumber>
<StrengthUnit>
g/100mL; g/100mL
</StrengthUnit>
<Pharm_Classes>
Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2026-01-28
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20251227
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>